These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14663036)

  • 1. Major depression in multiple sclerosis: a population-based perspective.
    Patten SB; Beck CA; Williams JV; Barbui C; Metz LM
    Neurology; 2003 Dec; 61(11):1524-7. PubMed ID: 14663036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity of major depression and migraine--a Canadian population-based study.
    Molgat CV; Patten SB
    Can J Psychiatry; 2005 Nov; 50(13):832-7. PubMed ID: 16483117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term medical conditions and major depression: strength of association for specific conditions in the general population.
    Patten SB; Beck CA; Kassam A; Williams JV; Barbui C; Metz LM
    Can J Psychiatry; 2005 Mar; 50(4):195-202. PubMed ID: 15898458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major depressive disorder and health care costs in multiple sclerosis.
    Patten SB; Jacobs P; Petcu R; Reimer MA; Metz LM
    Int J Psychiatry Med; 2002; 32(2):167-78. PubMed ID: 12269597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point prevalence and correlates of depression in a national community sample with multiple sclerosis.
    Viner R; Fiest KM; Bulloch AG; Williams JV; Lavorato DH; Berzins S; Jetté N; Metz LM; Patten SB
    Gen Hosp Psychiatry; 2014; 36(3):352-4. PubMed ID: 24559790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidity in epilepsy: a population-based analysis.
    Tellez-Zenteno JF; Patten SB; Jetté N; Williams J; Wiebe S
    Epilepsia; 2007 Dec; 48(12):2336-44. PubMed ID: 17662062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with perceived need for mental health care in multiple sclerosis.
    Orr J; Bernstein CN; Graff LA; Patten SB; Bolton JM; Sareen J; Marriott JJ; Fisk JD; Marrie RA;
    Mult Scler Relat Disord; 2018 Oct; 25():179-185. PubMed ID: 30096684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional variation of multiple sclerosis prevalence in Canada.
    Beck CA; Metz LM; Svenson LW; Patten SB
    Mult Scler; 2005 Oct; 11(5):516-9. PubMed ID: 16193887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Profile of Persons with Multiple Sclerosis Across the Continuum of Care.
    Turcotte LA; Marrie RA; Patten SB; Hirdes JP
    Can J Neurol Sci; 2018 Mar; 45(2):188-198. PubMed ID: 29251260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric co-morbidity in multiple sclerosis: The risk of depression and anxiety before and after MS diagnosis.
    Hoang H; Laursen B; Stenager EN; Stenager E
    Mult Scler; 2016 Mar; 22(3):347-53. PubMed ID: 26041803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Employment and absenteeism in working-age persons with multiple sclerosis.
    Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
    J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive epidemiology of major depression in Canada.
    Patten SB; Wang JL; Williams JV; Currie S; Beck CA; Maxwell CJ; El-Guebaly N
    Can J Psychiatry; 2006 Feb; 51(2):84-90. PubMed ID: 16989107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2.
    Patten SB
    J Affect Disord; 2001 Mar; 63(1-3):35-41. PubMed ID: 11246078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population.
    Patten SB; Metz LM; Reimer MA
    Mult Scler; 2000 Apr; 6(2):115-20. PubMed ID: 10773857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depression, fibromyalgia and labour force participation: a population-based cross-sectional study.
    Kassam A; Patten SB
    BMC Musculoskelet Disord; 2006 Jan; 7():4. PubMed ID: 16423291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples.
    Patten SB
    Chronic Dis Can; 1997; 18(3):109-12. PubMed ID: 9375257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous corticosteroids and major depression in the general population.
    Patten SB
    J Psychosom Res; 2000 Dec; 49(6):447-9. PubMed ID: 11182439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrecognised symptoms of depression in a community-based population with multiple sclerosis.
    McGuigan C; Hutchinson M
    J Neurol; 2006 Feb; 253(2):219-23. PubMed ID: 16177840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol consumption and major depression in the Canadian population.
    Patten SB; Charney DA
    Can J Psychiatry; 1998 Jun; 43(5):502-6. PubMed ID: 9653535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement issues related to the evaluation and monitoring of major depression prevalence in Canada.
    Patten SB; Wang JL; Beck CA; Maxwell CJ
    Chronic Dis Can; 2005; 26(4):100-6. PubMed ID: 16390627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.